Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting of an NIH Blue Ribbon Panel, 54841-54842 [E8-22313]

Download as PDF Federal Register / Vol. 73, No. 185 / Tuesday, September 23, 2008 / Notices 54841 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Name of Committee: Board of Scientific Counselors, National Institute of Neurological Disorders and Stroke. Date: October 5–7, 2008. Time: October 5, 2008, 7 p.m. to 10 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814. Time: October 6, 2008, 8:30 a.m. to 2:10 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room A, Rockville, MD 20852. Time: October 6, 2008, 3:10 p.m. to 8:10 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814. Time: October 7, 2008, 8:30 a.m. to 12 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814. Contact Person: Alan P. Koretsky, PhD, Scientific Director, Division of Intramural Research, National Institute of Neurological Disorders & Stroke, NIH, 35 Convent Drive, Room 6a 908, Bethesda, MD 20892, 301–435– 2232, koretskya@ninds.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) jlentini on PROD1PC65 with NOTICES competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Cancer Institute; Notice of Closed Meeting National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2) notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5 U.S.C., as amended. The purpose of this meeting is to evaluate requests for preclinical development resources for potential new therapeutics for the treatment of cancer. The outcome of the evaluation will be a decision whether NCI should support request(s) and make available contract resources for development of the potential therapeutic to improve the treatment of various forms of cancer. The research proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the proposed research projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: September 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–22309 Filed 9–22–08; 8:45 am] BILLING CODE 4140–01–P Name of Committee: National Cancer Institute Special Emphasis Panel; Rapid Access to Intervention Development. Date: November 5–6, 2008. Time: 1 p.m.–5 p.m. Agenda: To evaluate the Rapid Access to Intervention Development Portfolio. Place: National Institutes of Health, Executive Plaza North, Conference Room H, 6130 Executive Boulevard, Rockville, MD 20852. Contact Person: Phyllis G. Bryant, Executive Secretary, Program Analyst, Developmental Therapeutics Program, National Cancer Institute, NIH, 6130 Executive Boulevard, Rm. 8022, Bethesda, MD 20892, (301) 496–8720, pb45q@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–22316 Filed 9–22–08; 8:45 am] BILLING CODE 4140–01–P VerDate Aug<31>2005 16:54 Sep 22, 2008 Jkt 214001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Name of Committee: National Institute on Aging Initial Review Group; Neuroscience of Aging Review Committee. Date: October 14–15, 2008. Time: 4 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: William Cruce, PhD, Scientific Review Administrator, National Institute on Aging, Scientific Review Office, Gateway Building 2C–212, 7201 Wisconsin Ave., Bethesda, MD 20814, 301–402–7704, crucew@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.866, Aging Research, National Institutes of Health, HHS) Dated: September 15, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–22057 Filed 9–22–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting of an NIH Blue Ribbon Panel There will be a meeting of the NIH Blue Ribbon Panel to advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories (NEIDL). The meeting will be held on Tuesday, October 14, 2008, at the Roxbury Center for the Arts, Hibernian Hall, 184 Dudley Street, Roxbury, MA E:\FR\FM\23SEN1.SGM 23SEN1 54842 Federal Register / Vol. 73, No. 185 / Tuesday, September 23, 2008 / Notices 02119 from approximately 6:30 p.m. to 9:30 p.m. Discussions will focus on principles and strategies for effective community engagement. There will also be time allotted on the agenda for public comment. Sign up for public comment will begin at approximately 5:30 p.m. on October 14, 2008. In the event that time does not allow for all those interested to present oral comments, anyone may file written comments using the address below. For further information concerning this meeting contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of the Director, National Institutes of Health, Mail Stop Code 7985, Bethesda, MD 20892–7985, telephone 301–496–9838, e-mail lewallla@od.nih.gov. Background information may be obtained by contacting NIH OBA by e-mail oba@od.nih.gov. Dated: September 16, 2008. Kelly R. Fennington, Special Assistant to the Director, Office of Biotechnology Activities, National Institutes of Health. [FR Doc. E8–22313 Filed 9–22–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG–2008–0961] Information Collection Request to Office of Management and Budget; OMB Control Number: 1625–0073 Coast Guard, DHS. Sixty-day notice requesting comments. AGENCY: (1) Online: https:// www.regulations.gov. (2) Mail: Docket Management Facility (DMF) (M–30), U.S. Department of Transportation (DOT), West Building Ground Floor, Room W12–140, 1200 New Jersey Avenue, SE., Washington, DC 20590–0001. (3) Hand deliver between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The telephone number is 202–366–9329. (4) Fax: 202–493–2251. The DMF maintains the public docket for this notice. Comments and material received from the public, as well as documents mentioned in this notice as being available in the docket, will become part of this docket and will be available for inspection or copying at room W12–140 on the West Building Ground Floor, 1200 New Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. You may also find this docket on the Internet at https://www.regulations.gov. A copy of the complete ICR is available through this docket on the Internet at https://www.regulations.gov. Additionally, copies are available from Commandant (CG–611), U.S. Coast Guard Headquarters, (Attn: Mr. Arthur Requina), 2100 2nd Street, SW., Washington, DC 20593–0001. The telephone number is 202–475–3523. FOR FURTHER INFORMATION CONTACT: Mr. Arthur Requina, Office of Information Management, telephone 202–475–3523, or fax 202–475–3929, for questions on these documents. Contact Ms. Renee V. Wright, Program Manager, Docket Operations, 202–366–9826, for questions on the docket. SUPPLEMENTARY INFORMATION: ACTION: Public Participation and Request for Comments. In compliance with the Paperwork Reduction Act of 1995, the U.S. Coast Guard intends to submit an Information Collection Request (ICR) and Analysis to the Office of Management and Budget (OMB) requesting an extension of its approval for the following collection of information: 1625–0073, Alteration of Unreasonable Obstructive Bridges. Before submitting this ICR to OMB, the Coast Guard is inviting comments as described below. DATES: Comments must reach the Coast Guard on or before November 24, 2008. ADDRESSES: To avoid duplicate submissions to the docket [USCG–2008– 0961], please use only one of the following means: The Coast Guard invites comments on whether this information collection request should be granted based on it being necessary for the proper performance of Departmental functions. In particular, the Coast Guard would appreciate comments addressing: (1) The practical utility of the collections; (2) the accuracy of the estimated burden of the collections; (3) ways to enhance the quality, utility, and clarity of information subject to the collections; and (4) ways to minimize the burden of collections on respondents, including the use of automated collection techniques or other forms of information technology. We encourage you to respond to this request by submitting comments and related materials. We will post all jlentini on PROD1PC65 with NOTICES SUMMARY: VerDate Aug<31>2005 16:54 Sep 22, 2008 Jkt 214001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 comments received, without change, to https://www.regulations.gov. They will include any personal information you provide. We have an agreement with DOT to use their DMF. Please see the paragraph on DOT’s ‘‘Privacy Act Policy’’ below. Submitting comments: If you submit a comment, please include the docket number [USCG–2008–0961], indicate the specific section of the document to which each comment applies, providing a reason for each comment. We recommend you include your name, mailing address, an e-mail address, or other contact information in the body of your document so that we can contact you if we have questions regarding your submission. You may submit your comments and material by electronic means, mail, fax, or delivery to the DMF at the address under ADDRESSES; but please submit them by only one means. If you submit them by mail or delivery, submit them in an unbound format, no larger than 81⁄2 by 11 inches, suitable for copying and electronic filing. If you submit them by mail and would like to know that they reached the Facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. We may change the documents supporting this collection of information or even the underlying requirements in view of them. Viewing comments and documents: Go to https://www.regulations.gov to view documents mentioned in this notice as being available in the docket. Enter the docket number for this notice [USCG–2008–0961] in the Search box, and click ‘‘Go >>.’’ You may also visit the DMF in room W12–140 on the West Building Ground Floor, 1200 New Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. Privacy Act: Anyone can search the electronic form of all comments received in dockets by the name of the individual submitting the comment (or signing the comment, if submitted on behalf of an association, business, labor union, etc.). You may review the Privacy Act statement regarding our public dockets in the January 17, 2008 issue of the Federal Register (73 FR 3316). Information Collection Request. Title: Alteration of Unreasonable Obstructive Bridges. OMB Control Number: 1625–0073. Summary: This collection of information is used to determine if a bridge is unreasonably obstructive. E:\FR\FM\23SEN1.SGM 23SEN1

Agencies

[Federal Register Volume 73, Number 185 (Tuesday, September 23, 2008)]
[Notices]
[Pages 54841-54842]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22313]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Office of 
Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting 
of an NIH Blue Ribbon Panel

    There will be a meeting of the NIH Blue Ribbon Panel to advise on 
the Risk Assessment of the National Emerging Infectious Diseases 
Laboratories (NEIDL). The meeting will be held on Tuesday, October 14, 
2008, at the Roxbury Center for the Arts, Hibernian Hall, 184 Dudley 
Street, Roxbury, MA

[[Page 54842]]

02119 from approximately 6:30 p.m. to 9:30 p.m.
    Discussions will focus on principles and strategies for effective 
community engagement. There will also be time allotted on the agenda 
for public comment.
    Sign up for public comment will begin at approximately 5:30 p.m. on 
October 14, 2008. In the event that time does not allow for all those 
interested to present oral comments, anyone may file written comments 
using the address below.
    For further information concerning this meeting contact Ms. Laurie 
Lewallen, Advisory Committee Coordinator, Office of Biotechnology 
Activities, Office of the Director, National Institutes of Health, Mail 
Stop Code 7985, Bethesda, MD 20892-7985, telephone 301-496-9838, e-mail 
lewallla@od.nih.gov. Background information may be obtained by 
contacting NIH OBA by e-mail oba@od.nih.gov.

    Dated: September 16, 2008.
Kelly R. Fennington,
Special Assistant to the Director, Office of Biotechnology Activities, 
National Institutes of Health.
[FR Doc. E8-22313 Filed 9-22-08; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.